| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Director
2 companies
Miller Joseph M is a Chief Financial Officer at Aurinia Pharmaceuticals Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 3 buys and 5 sells.
Estimated insider holdings value: $10.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2025 | AUPH Aurinia Pharmaceuticals Inc. | Chief Financial Officer | Sell | 118,013 | $7.96 | $939,611.68 | -8.9% | -1.5% | +86.1% | |
| Mar 6, 2024 | AUPH Aurinia Pharmaceuticals Inc. | Chief Financial Officer | Sell | 34,811 | $5.60 | $194,941.60 | -6.6% | -4.5% | +48.4% | |
| Mar 2, 2023 | AUPH Aurinia Pharmaceuticals Inc. | Chief Financial Officer | Sell | 11,296 | $8.94 | $100,986.24 | -3.3% | +0.2% | -35.3% | |
| Mar 2, 2022 | AUPH Aurinia Pharmaceuticals Inc. | Chief Financial Officer | Sell | 3,060 | $12.01 | $36,750.60 | -31.6% | -2.9% | -23.1% | |
| May 11, 2021 | AUPH Aurinia Pharmaceuticals Inc. | Chief Financial Officer | Buy | 1,000 | $9.74 | $9,740.00 | New | +39.7% | -14.7% | |
| Dec 10, 2019 | AVTX Avalo Therapeutics, Inc. | Chief Financial Officer | Buy | 2,598 | $2.85 | $7,397.81 | +5.6% | - | - | |
| Jun 10, 2019 | AVTX Avalo Therapeutics, Inc. | Chief Financial Officer | Buy | 1,179 | $2.85 | $3,357.20 | +2.6% | - | - |